The data illustrates the Overall pharmaceutical company ranking of the Access to Medicine Index for developing countries in 2016. In that year, GlaxoSmithKline with 3.43 had the highest total score. The Access to Medicine Index is an independent initiative that ranks the world’s
20 biggest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.
